Personalized and precision medicine: the future of tailored treatments discussed at PEMED 2021, chaired by the Josep Carreras Leukaemia Research Institute
The Josep Carreras Leukaemia Research Institute, new Member Institution at the International Cancer Proteogenome Consortium of the National Cancer Institute